{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:33Z","timestamp":1790957973511,"version":"4.1.0"},"reference-count":121,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,4,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Diabetes Mellitus (DM), is a metabolic disorder characterized by high blood glucose\nlevels. The main types of diabetes mellitus are Diabetes mellitus type I, Diabetes mellitus type II, gestational\ndiabetes and Diabetes of other etiology. Diabetes type II, the Non Insulin Dependent Type (NIDDM) is the most\ncommon type, characterized by the impairment in activation of the intracellular mechanism leading to the insertion\nand usage of glucose after interaction of insulin with its receptor, known as insulin resistance. Although, a\nnumber of drugs have been developed for the treatment of diabetes type II, their ability to reduce blood glucose\nlevels is limited, while several side effects are also observed. Furthermore, none of the market drugs targets the\nenhancement of the action of the intracellular part of insulin receptor or recuperation of the glucose transport\nmechanism in GLUT4 dependent cells. The Protein Tyrosine Phosphatase (PTP1b) is the main enzyme involved\nin insulin receptor desensitization and has become a drug target for the treatment of Diabetes type II. Several\nPTP1b inhibitors have already been found, interacting with the binding site of the enzyme, surrounding the catalytic\namino acid Cys215 and the neighboring area or with the allosteric site of the enzyme, placed at a distance\nof 20 \u00c5 from the active site, around Phe280. However, the research continues for finding more potent inhibitors\nwith increased cell permeability and specificity.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> The aim of this review is to show the attempts made in developing of Protein Tyrosine Phosphatase\n(PTP1b) inhibitors with high potency, selectivity and bioavailability and to sum up the indications for favorable\nstructural characteristics of effective PTP1b inhibitors.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods: <\/jats:title>\n<jats:p>The methods used include a literature survey and the use of Protein Structure Databanks such as\nPuBMed Structure and RCSB and the tools they provide.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>The research for finding PTP1b inhibitors started with the design of molecules mimicking the Tyrosine\nsubstrate of the enzyme. The study revealed that an aromatic ring connected to a polar group, which preferably\nenables hydrogen bond formation, is the minimum requirement for small inhibitors binding to the active\nsite surrounding Cys215. Molecules bearing two hydrogen bond donor\/acceptor (Hb d\/a) groups at a distance of\n8.5-11.5 \u00c5 may form more stable complexes, interacting simultaneously with a secondary area A2. Longer molecules\nwith two Hb d\/a groups at a distance of 17 \u00c5 or 19 \u00c5 may enable additional interactions with secondary\nsites (B and C) that confer stability as well as specificity. An aromatic ring linked to polar or Hb d\/a moieties is\nalso required for allosteric inhibitors. A lower distance between Hb d\/a moieties, around 7.5 \u00c5 may favor allosteric\ninteraction. Permanent inhibition of the enzyme by oxidation of the catalytic Cys215 has also been referred.\nMoreover, covalent modification of Cys121, placed near but not inside the catalytic pocket has been\nassociated with permanent inhibition of the enzyme.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026619666190201152153","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T06:56:32Z","timestamp":1549263392000},"page":"246-263","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II"],"prefix":"10.2174","volume":"19","author":[{"given":"Phaedra","family":"Eleftheriou","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Studies, School of Health and Medical Care, Alexander Technological Educational Institute of Thessaloniki, Thessaloniki 57400, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Geronikaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthi","family":"Petrou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"241","volume":"88","author":"Vats R.K.","year":"2005","unstructured":"Vats RK, Kumar V, Kothari A, Mital A, Ramachandran U.  Emerging targets for diabetes.","journal-title":"Curr Sci"},{"key":"ref=2","author":"","year":"","unstructured":".  Global report on Diabetes. World Health Organization 2016. ISBN 978 92 4 156525 7 (NLM classification: WK 810)"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"van Belle T.L.","year":"2011","unstructured":"van Belle TL, Coppieters KT, von Herrath MG.  Type 1 diabetes: etiology, immunology, and therapeutic strategies.","journal-title":"Physiol Rev"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","volume":"365","author":"Stumvoll M.","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW.  Type 2 diabetes: principles of pathogenesis and therapy.","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/jme.1.01694","volume":"34","author":"Lund I.K.","year":"2005","unstructured":"Lund IK, Hansen JA, Andersen HS, M\u00f8ller NP, Billestrup N.  Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.","journal-title":"J Mol Endocrinol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1043-2760(03)00031-6","volume":"14","author":"Morral N.","year":"2003","unstructured":"Morral N.  Novel targets and therapeutic strategies for type 2 diabetes.","journal-title":"Trends Endocrinol Metab"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1381612013397915","volume":"7","author":"Wagman A.S.","year":"2001","unstructured":"Wagman AS, Nuss JM.  Current therapies and emerging targets for the treatment of diabetes.","journal-title":"Curr Pharm Des"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","volume":"11","author":"Sola D.","year":"2015","unstructured":"Sola D, Rossi L, Piero G, Schianca C, Maffioli P, Bigliocca M, Mella R, Corlian\u00f2 F, Fra G, Bartoli E, Derosa G.  Sulfonylureas and their use in clinical practice.","journal-title":"Arch Med Sci"},{"key":"ref=9","first-page":"S1","volume":"14","author":"Amos A.F.","year":"1997","unstructured":"Amos AF, McCarty DJ, Zimmet P.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.","journal-title":"Diabet Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02703748","volume":"26","author":"Balasubramanyam M.","year":"2001","unstructured":"Balasubramanyam M, Mohan V.  Orally active insulin mimics: where do we stand now?","journal-title":"J Biosci"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bbadis.2013.05.022","volume":"1832","author":"Hendriks W.J.A.J.","year":"2013","unstructured":"Hendriks WJAJ, Pulido R.  Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities.","journal-title":"Biochim Biophys Acta"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","volume":"283","author":"Elchebly M.","year":"1999","unstructured":"Elchebly M, Payette P, Michaliszyn E.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.","journal-title":"Science"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"Nathan D.M.","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.  Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.","journal-title":"Diabetes Care"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14728222.10.1.157","volume":"10","author":"Tautz L.","year":"2006","unstructured":"Tautz L, Pellecchia M, Mustelin T.  Targeting the PTPome in human disease.","journal-title":"Expert Opin Ther Targets"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1021\/jm010020r","volume":"44","author":"Gao Y.","year":"2001","unstructured":"Gao Y, Voigt J, Zhao H, Pais GC, Zhang X, Wu L, Zhang ZY, Burke TR.  Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif.","journal-title":"J Med Chem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/157340608783331515","volume":"4","author":"Dixit M.","year":"2008","unstructured":"Dixit M, Saeed U, Kumar A, Siddiqi MI, Tamrakar AK, Srivastava AK, Goel A.  Synthesis, molecular docking and PTP1B inhibitory activity of functionalized 4,5-dihydronaphthofurans and dibenzofurans.","journal-title":"Med Chem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1021\/bi035098j","volume":"42","author":"Scapin G.","year":"2003","unstructured":"Scapin G, Patel SB, Becker JW, Wang Q, Desponts C, Waddleton D, Skorey K, Cromlish W, Bayly C, Therien M, Gauthier JY, Li CS, Lau CK, Ramachandran C, Kennedy BP, Asante-Appiah E.  The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.","journal-title":"Biochemistry"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.94.25.13420","volume":"94","author":"Puius Y.A.","year":"1997","unstructured":"Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.bmc.2005.11.005","volume":"14","author":"Moretto A.F.","year":"2006","unstructured":"Moretto AF, Kirincich SJ, Xu WX, Smith MJ, Wan ZK, Wilson DP, Follows BC, Binnun E, Joseph-McCarthy D, Foreman K, Erbe DV, Zhang YL, Tam SK, Tam SY, Lee J.  Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors.","journal-title":"Bioorg Med Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.bmcl.2005.12.051","volume":"16","author":"Klopfenstein S.R.","year":"2006","unstructured":"Klopfenstein SR, Evdokimov AG, Colson AO, Fairweather NT, Neuman JJ, Maier MB, Gray JL, Gerwe GS, Stake GE, Howard BW, Farmer JA, Pokross ME, Downs TR, Kasibhatla B, Peters KG.  1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1021\/jm0205696","volume":"46","author":"Liu G.","year":"2003","unstructured":"Liu G, Szczepankiewicz BG, Pei Z, Janowick DA, Xin Z, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR.  Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1021\/jm010266w","volume":"44","author":"Jia Z.","year":"2001","unstructured":"Jia Z, Ye Q, Dinaut AN, Wang Q, Waddleton D, Payette P, Ramachandran C, Kennedy B, Hum G, Taylor SD.  Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1021\/jm010393s","volume":"45","author":"Larsen S.D.","year":"2002","unstructured":"Larsen SD, Barf T, Liljebris C, May PD, Ogg D, O\u2019Sullivan TJ, Palazuk BJ, Schostarez HJ, Stevens FC, Bleasdale JE.  Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1B.","journal-title":"J Med Chem"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1074\/jbc.M511827200","volume":"281","author":"Asante-Appiah E.","year":"2006","unstructured":"Asante-Appiah E, Patel S, Desponts C, Taylor JM, Lau C, Dufresne C, Therien M, Friesen R, Becker JW, Leblanc Y, Kennedy BP, Scapin G.  Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase.","journal-title":"J Biol Chem"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.bmcl.2006.06.051","volume":"16","author":"Wan Z.K.","year":"2006","unstructured":"Wan ZK, Lee J, Xu W, Erbe DV, Joseph-McCarthy D, Follows BC, Zhang YL.  Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bmcl.2007.11.012","volume":"18","author":"Douty B.","year":"2008","unstructured":"Douty B, Wayland B, Ala PJ, Bower MJ, Pruitt J, Bostrom L, Wei M, Klabe R, Gonneville L, Wynn R, Burn TC, Liu PC, Combs AP, Yue EW.  Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/bi002865v","volume":"40","author":"Bleasdale J.E.","year":"2001","unstructured":"Bleasdale JE, Ogg D, Palazuk BJ, Jacob CS, Swanson ML, Wang XY, Thompson DP, Conradi RA, Mathews WR, Laborde AL, Stuchly CW, Heijbel A, Bergdahl K, Bannow CA, Smith CW, Svensson C, Liljebris C, Schostarez HJ, May PD, Stevens FC, Larsen SD.  Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.","journal-title":"Biochemistry"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1074\/jbc.M212491200","volume":"278","author":"Sun J.P.","year":"2003","unstructured":"Sun JP, Fedorov AA, Lee SY, Guo XL, Shen K, Lawrence DS, Almo SC, Zhang ZY.  Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor.","journal-title":"J Biol Chem"},{"key":"ref=29","first-page":"72","volume":"2","author":"Eleftheriou P.","year":"2013","unstructured":"Eleftheriou P.  The protein tyrosine phosphatase 1b as a drug target for the treatment of diabetes type II. Developing effective and selective PTP1B inhibitors.","journal-title":"ChemXPress"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/1062936X.2015.1074939","volume":"26","author":"Eleftheriou P.","year":"2015","unstructured":"Eleftheriou P, Petrou A, Geronikaki A, Liaras K, Dirnali S, Anna M.  Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor\/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.","journal-title":"SAR QSAR Environ Res"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4155\/fmc.10.241","volume":"2","author":"Barr A.J.","year":"2010","unstructured":"Barr AJ.  Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.","journal-title":"Future Med Chem"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb803","volume":"11","author":"Wiesmann C.","year":"2004","unstructured":"Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK.  Allosteric inhibition of protein tyrosine phosphatase 1B.","journal-title":"Nat Struct Mol Biol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/1062936X.2017.1414874","volume":"29","author":"Ganou C.A.","year":"2018","unstructured":"Ganou CA, Eleftheriou PT, Theodosis-Nobelos P, Fesatidou M, Geronikaki AA, Lialiaris T, Rekka EA.  Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives.","journal-title":"SAR QSAR Environ Res"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/S0968-0896(02)00062-7","volume":"10","author":"Leung C.","year":"2002","unstructured":"Leung C, Grzyb J, Lee J, Meyer N, Hum G, Jia C, Liu S, Taylor SD.  The difluoromethylenesulfonic acid group as a monoanionic phosphate surrogate for obtaining PTP1B inhibitors.","journal-title":"Bioorg Med Chem"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1016\/j.bmcl.2008.06.029","volume":"18","author":"Bhattacharya S.","year":"2008","unstructured":"Bhattacharya S, Labutti JN, Seiner DR, Gates KS.  Oxidative inactivation of protein tyrosine phosphatase 1B by organic hydroperoxides.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/09298665113209990089","volume":"21","author":"Reddy M.V.","year":"2014","unstructured":"Reddy MV, Ghadiyaram C, Panigrahi SK, Krishnamurthy NR, Hosahalli S, Chandrasekharappa AP, Manna D, Badiger SE, Dubey PK, Mangamoori LN.  X-ray structure of PTP1B in complex with a new PTP1B inhibitor.","journal-title":"Protein Pept Lett"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1021\/acs.biochem.7b00151","volume":"56","author":"Punthasee P.","year":"2017","unstructured":"Punthasee P, Laciak AR, Cummings AH, Ruddraraju KV, Lewis SM, Hillebrand R, Singh H, Tanner JJ, Gates KS.  Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.","journal-title":"Biochemistry"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"7704","DOI":"10.1021\/bi047417s","volume":"44","author":"Hansen S.K.","year":"2005","unstructured":"Hansen SK, Cancilla MT, Shiau TP, Kung J, Chen T, Erlanson DA.  Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue.","journal-title":"Biochemistry"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0960-894X(00)00124-4","volume":"10","author":"Gao Y.","year":"2000","unstructured":"Gao Y, Wu L, Luo JH, Guo R, Yang D, Zhang ZY, Burke TR.  Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1016\/S0040-4020(98)00590-0","volume":"54","author":"Burke T.R.","year":"1998","unstructured":"Burke TR, Yao JZ, Zhao H, Wu L, Zhang Z-Y, Voigt J.  Enatioselective synthesis of nonphosphorus-containing phosphotyrosine mimetics and their use in preparation of tyrosine phosphatase inhibitory peptides.","journal-title":"Tetrahedron"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0960-894X(02)01065-X","volume":"13","author":"Larsen S.D.","year":"2003","unstructured":"Larsen SD, Stevens FC, Lindberg TJ, Bodnar PM, O\u2019Sullivan TJ, Schostarez HJ, Palazuk BJ, Bleasdale JE.  Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/jo034113n","volume":"68","author":"Chen Y.T.","year":"2003","unstructured":"Chen YT, Onaran MB, Doss DJ, Seto CT.  Alpha-Ketocarboxylic Acid-Based Inhibitors of Protein Tyrosine Phosphatases.","journal-title":"J Org Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1016\/j.bmcl.2008.10.091","volume":"18","author":"Lin L.","year":"2008","unstructured":"Lin L, Shen Q, Chen G-R, Xie J.  \u03b2-C-glycosiduronic acids and \u03b2-C-glycosyl compounds: new PTP1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1074\/jbc.275.14.10300","volume":"275","author":"Iversen L.F.","year":"2000","unstructured":"Iversen LF, Andersen HS, Branner S, Mortensen SB, Peters GH, Norris K, Olsen OH, Jeppesen CB, Lundt BF, Ripka W, M\u00f8ller KB, M\u00f8ller NP.  Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B.","journal-title":"J Biol Chem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/S0960-894X(02)00768-0","volume":"12","author":"Hum G.","year":"2002","unstructured":"Hum G, Lee J, Taylor SD.  Synthesis of [difluoro-(3-alkenylphenyl)-methyl]-phosphonic acids on non-crosslinked polystyrene and their evaluation as inhibitors of PTP1B.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.ejmech.2010.05.020","volume":"45","author":"Lakshminarayana N.","year":"2010","unstructured":"Lakshminarayana N, Prasad YR, Gharat L, Thomas A, Narayanan S, Raghuram A, Srinivasan CV, Gopalan B.  Synthesis and evaluation of some novel dibenzo[]furan carboxylic acids as potential anti-diabetic agents.","journal-title":"Eur J Med Chem"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0960-894X(03)00302-0","volume":"13","author":"Xin Z.","year":"2003","unstructured":"Xin Z, Oost TK, Abad-Zapatero C, Hajduk PJ, Pei Z, Szczepankiewicz BG, Hutchins CW, Ballaron SJ, Stashko MA, Lubben T, Trevillyan JM, Jirousek MR, Liu G.  Potent, selective inhibitors of protein tyrosine phosphatase 1B.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bmc.2011.11.004","volume":"20","author":"He R-J.","year":"2012","unstructured":"He R-J, Yu Z-H, Zhang R-Y, Zhang Z-Y.  Protein Tyrosine Phosphatases as Potential Therapeutic Targets.","journal-title":"Bioorg Med Chem"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bmcl.2011.11.122","volume":"22","author":"Patel D.","year":"2012","unstructured":"Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Joharapurkar A, Dhanesha N, Shaikh M, Sairam KV, Kapadnis P.  Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/S0960-894X(02)00681-9","volume":"12","author":"Arabaci G.","year":"2002","unstructured":"Arabaci G, Yi T, Fu H, Porter ME, Beebe KD, Pei D.  alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1016\/j.bmc.2008.07.090","volume":"16","author":"Shrestha S.","year":"2008","unstructured":"Shrestha S, Bhattarai BR, Kafle B, Lee K-H, Cho H.  Derivatives of 1,4-bis(3-hydroxycarbonyl-4-hydroxyl)styrylbenzene as PTP1B inhibitors with hypoglycemic activity.","journal-title":"Bioorg Med Chem"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.ejmech.2011.06.025","volume":"46","author":"Li C.","year":"2011","unstructured":"Li C, He XP, Zhang YJ, Li Z, Gao LX, Shi XX, Xie J, Li J, Chen GR, Tang Y.  Click to a focused library of benzyl 6-triazolo(hydroxy)benzoic glucosides: novel construction of PTP1B inhibitors on a sugar scaffold.","journal-title":"Eur J Med Chem"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carres.2010.10.023","volume":"346","author":"Song Z.","year":"2011","unstructured":"Song Z, He X-P, Li C, Gao LX, Wang Z-X, Tang Y, Xie J, Li J, Chen GR.  Preparation of triazole-linked glycosylated \u03b1-ketocarboxylic acid derivatives as new PTP1B inhibitors.","journal-title":"Carbohydr Res"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1016\/j.bmc.2008.09.066","volume":"16","author":"Lin L.","year":"2008","unstructured":"Lin L, Shen Q, Chen GR, Xie J.  Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.","journal-title":"Bioorg Med Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.ejmech.2009.03.009","volume":"44","author":"Lakshminarayana N.","year":"2009","unstructured":"Lakshminarayana N, Rajendra Prasad Y, Gharat L, Thomas A, Ravikumar P, Narayanan S, Srinivasan CV, Gopalan B.  Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents.","journal-title":"Eur J Med Chem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0960-894X(03)00479-7","volume":"13","author":"Shim Y.S.","year":"2003","unstructured":"Shim YS, Kim KC, Chi DY, Lee K-H, Cho H.  Formylchromone derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.bmc.2009.11.061","volume":"18","author":"Kumar A.","year":"2010","unstructured":"Kumar A, Sharma S, Tripathi VD, Maurya RA, Srivastava SP, Bhatia G, Tamrakar AK, Srivastava AK.  Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents.","journal-title":"Bioorg Med Chem"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0960-894X(02)00331-1","volume":"12","author":"Ahn J.H.","year":"2002","unstructured":"Ahn JH, Cho SY, Ha JD, Chu SY, Jung S-H, Jung Y-S, Baek J-Y, Choi IK, Shin E-Y, Kang S-K, Kim S-S, Cheon HG, Yang S-D, Choi JK.  Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/S0968-0896(02)00176-1","volume":"10","author":"Liljebris C.","year":"2002","unstructured":"Liljebris C, Martinsson J, Tedenborg L, Williams M, Barker E, Duffy JE, Nygren A, James S.  Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B).","journal-title":"Bioorg Med Chem"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/j.bmcl.2010.08.008","volume":"20","author":"Gupta S.","year":"2010","unstructured":"Gupta S, Pandey G, Rahuja N, Srivastava AK, Saxena AK.  Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.bmcl.2011.05.052","volume":"21","author":"Xie J.","year":"2011","unstructured":"Xie J, Tian J, Su L, Huang M, Zhu X, Ye F, Wan Y.  Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1016\/j.bmcl.2011.04.057","volume":"21","author":"Liu Z.","year":"2011","unstructured":"Liu Z, Lee W, Kim S-N, Yoon G, Cheon SH.  Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1016\/j.bmcl.2009.10.017","volume":"19","author":"Qiu W-W.","year":"2009","unstructured":"Qiu W-W, Shen Q, Yang F, Wang B, Zou H, Li J-Y, Li J, Tang J.  Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/cbdv.201000242","volume":"8","author":"Luo L.","year":"2011","unstructured":"Luo L, He XP, Shen Q, Li JY, Shi XX, Xie J, Li J, Chen GR.  Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B).","journal-title":"Chem Biodivers"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.bmcl.2010.08.130","volume":"20","author":"Bhattarai B.R.","year":"2010","unstructured":"Bhattarai BR, Kafle B, Hwang J-S, Ham SW, Lee K-H, Park H, Han I-O, Cho H.  Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-\u03b3 activators.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1016\/j.bmcl.2009.09.020","volume":"19","author":"Bhattarai B.R.","year":"2009","unstructured":"Bhattarai BR, Kafle B, Hwang J-S, Khadka D, Lee SM, Kang JS, Ham SW, Han IO, Park H, Cho H.  Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.bmc.2009.01.044","volume":"17","author":"Ottan\u00e0 R.","year":"2009","unstructured":"Ottan\u00e0 R, Maccari R, Ciurleo R, Paoli P, Jacomelli M, Manao G, Camici G, Laggner C, Langer T.  5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.","journal-title":"Bioorg Med Chem"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1016\/j.bmc.2008.09.066","volume":"16","author":"Lin L.","year":"2008","unstructured":"Lin L, Shen Q, Chen GR, Xie J.  Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B.","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jinorgbio.2011.07.008","volume":"105","author":"Lu L.","year":"2011","unstructured":"Lu L, Yue J, Yuan C, Zhu M, Han H, Liu Z, Guo M.  Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.","journal-title":"J Inorg Biochem"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10534-010-9363-8","volume":"23","author":"Lu L.","year":"2010","unstructured":"Lu L, Wang S, Zhu M, Liu Z, Guo M, Xing S, Fu X.  Inhibition protein tyrosine phosphatases by an oxovanadium glutamate complex, Na[VO(Glu)(CHOH)](Glu = glutamate).","journal-title":"Biometals"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jinorgbio.2010.05.003","volume":"104","author":"Yuan C.","year":"2010","unstructured":"Yuan C, Lu L, Wu Y, Liu Z, Guo M, Xing S, Fu X, Zhu M.  Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with Schiff base and polypyridyl derivatives.","journal-title":"J Inorg Biochem"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00775-009-0496-6","volume":"14","author":"Yuan C.","year":"2009","unstructured":"Yuan C, Lu L, Gao X, Wu Y, Guo M, Li Y, Fu X, Zhu M.  Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.","journal-title":"J Biol Inorg Chem"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10534-011-9460-3","volume":"24","author":"Li Y.","year":"2011","unstructured":"Li Y, Lu L, Zhu M, Wang Q, Yuan C, Xing S, Fu X, Mei Y.  Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.","journal-title":"Biometals"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1016\/S0040-4020(98)00590-0","volume":"54","author":"Terrence R.","year":"1998","unstructured":"Terrence R.  Burke, Jr., Zhu-Jun Yao, He Zhao, George W. A. Milne, Li Wu, Zhong-Yin Zhang and Johannes H. Voigt. Enantioselective Synthesis of Nonphosphorus-Containing Phosphotyrosyl Mimetics and Their Use in the Preparation of Tyrosine Phosphatase Inhibitory Peptides.","journal-title":"Tetrahedron"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0960-894X(00)00124-4","volume":"10","author":"Gao Y.","year":"2000","unstructured":"Gao Y, Wu L, Luo JH, Guo R, Yang D, Zhang ZY, Burke TR.  Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1021\/jm0504555","volume":"48","author":"Combs A.P.","year":"2005","unstructured":"Combs AP, Yue EW, Bower M, Ala PJ, Wayland B, Douty B, Takvorian A, Polam P, Wasserman Z, Zhu W, Crawley ML, Pruitt J, Sparks R, Glass B, Modi D, McLaughlin E, Bostrom L, Li M, Galya L, Blom K, Hillman M, Gonneville L, Reid BG, Wei M, Becker-Pasha M, Klabe R, Huber R, Li Y, Hollis G, Burn TC, Wynn R, Liu P, Metcalf B.  Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.","journal-title":"J Med Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.bmc.2006.05.032","volume":"14","author":"Yue E.W.","year":"2006","unstructured":"Yue EW, Wayland B, Douty B, Crawley ML, McLaughlin E, Takvorian A, Wasserman Z, Bower MJ, Wei M, Li Y, Ala PJ, Gonneville L, Wynn R, Burn TC, Liu PC, Combs AP.  Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1021\/jm0600904","volume":"49","author":"Combs A.P.","year":"2006","unstructured":"Combs AP, Zhu W, Crawley ML, Glass B, Polam P, Sparks RB, Modi D, Takvorian A, McLaughlin E, Yue EW, Wasserman Z, Bower M, Wei M, Rupar M, Ala PJ, Reid BM, Ellis D, Gonneville L, Emm T, Taylor N, Yeleswaram S, Li Y, Wynn R, Burn TC, Hollis G, Liu PC, Metcalf B.  Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.","journal-title":"J Med Chem"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bmcl.2006.10.079","volume":"17","author":"Sparks R.B.","year":"2007","unstructured":"Sparks RB, Polam P, Zhu W, Crawley ML, Takvorian A, McLaughlin E, Wei M, Ala PJ, Gonneville L, Taylor N, Li Y, Wynn R, Burn TC, Liu PC, Combs AP.  Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/aps.2010.81","volume":"31","author":"Liu Z.","year":"2010","unstructured":"Liu Z, Chai Q, Li Y-Y, Shen Q, Ma L-P, Zhang L-N, Wang X, Sheng L, Li JY, Li J, Shen JK.  Discovery of novel PTP1B inhibitors with antihyperglycemic activity.","journal-title":"Acta Pharmacol Sin"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/np100064m","volume":"73","author":"Qian S.","year":"2010","unstructured":"Qian S, Li H, Chen Y, Zhang W, Yang S, Wu Y.  Synthesis and biological evaluation of oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.","journal-title":"J Nat Prod"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/molecules19010102","volume":"19","author":"Wang W-L.","year":"2013","unstructured":"Wang W-L, Yang D-L, Gao L-X, Tang C-L, Ma W-P, Ye H-H, Zhang S-Q, Zhao Y-N, Xu H-J, Hu Z, Chen X, Fan W-H, Chen H-J, Li JY, Nan F-J, Li J, Feng B.  1H-2,3-dihydroperimidine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.","journal-title":"Molecules"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1016\/j.bmc.2015.05.032","volume":"23","author":"Du Y.","year":"2015","unstructured":"Du Y, Ling H, Zhang M, Shen J, Li Q.  Discovery of novel, potent, selective and cellular active ADC type PTP1B inhibitors via fragment-docking-oriented de novel design.","journal-title":"Bioorg Med Chem"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1021\/jm0702478","volume":"50","author":"Wilson D.P.","year":"2007","unstructured":"Wilson DP, Wan ZK, Xu WX, Kirincich SJ, Follows BC, Joseph-McCarthy D, Foreman K, Moretto A, Wu J, Zhu M, Binnun E, Zhang YL, Tam M, Erbe DV, Tobin J, Xu X, Leung L, Shilling A, Tam SY, Mansour TS, Lee J.  Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S1097-2765(00)00137-4","volume":"6","author":"Salmeen A.","year":"2000","unstructured":"Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.","journal-title":"Mol Cell"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"38013","DOI":"10.1074\/jbc.M607913200","volume":"281","author":"Ala P.J.","year":"2006","unstructured":"Ala PJ, Gonneville L, Hillman M, Becker-Pasha M, Yue EW, Douty B, Wayland B, Polam P, Crawley ML, McLaughlin E, Sparks RB, Glass B, Takvorian A, Combs AP, Burn TC, Hollis GF, Wynn R.  Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B.","journal-title":"J Biol Chem"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1016\/j.bmc.2015.09.024","volume":"23","author":"Liu P.","year":"2015","unstructured":"Liu P, Du Y, Song L, Shen J, Li Q.  Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejmech.2016.04.014","volume":"118","author":"Liu P.","year":"2016","unstructured":"Liu P, Du Y, Song L, Shen J, Li Q.  Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bmcl.2015.12.097","volume":"26","author":"Zhang L.","year":"2016","unstructured":"Zhang L, Jiang CS, Gao L-X, Gong J-X, Wang Z-H, Li J-Y, Li J, Li X-W, Guo Y-W.  Design, synthesis and  activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ejmech.2016.05.060","volume":"122","author":"Meng G.","year":"2016","unstructured":"Meng G, Zheng M, Wang M, Tong J, Ge W, Zhang J, Zheng A, Li J, Gao L, Li J.  Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.","journal-title":"Eur J Med Chem"},{"key":"ref=91","author":"Tang X.","year":"","unstructured":"Tang X, Zhang X, Chen Z, Yin W, Nan G, Tian J, Ye F, Xiao IZ.  Novel benzamido derivatives as PTP1B inhibitors with antiypertglycemic andlipidlowering efficacy.","journal-title":"Acta Pharm Sin B"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.bmcl.2013.02.073","volume":"23","author":"Tang Y.B.","year":"2013","unstructured":"Tang YB, Lu D, Chen Z, Hu C, Yang Y, Tian JY, Ye F, Wu L, Zhang ZY, Xiao Z.  Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.5012\/bkcs.2013.34.4.1275","volume":"34","author":"Nilkanth A.G.","year":"2013","unstructured":"Nilkanth AG, Bhooshan K, Hyeongjin C.  Thiazolidinone Derivatives as Competitive Inhibitors of Pro-tein Tyrosine Phosphatase 1B (PTP1B).","journal-title":"Bulletin of the Korean Chemical Society"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bmcl.2005.11.071","volume":"16","author":"Cui L.","year":"2006","unstructured":"Cui L, Na M, Oh H, Bae EY, Jeong DG, Ryu SE, Kim S, Kim BY, Oh WK, Ahn JS.  Protein tyrosine phosphatase 1B inhibitors from Morus root bark.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2005-873194","volume":"72","author":"Na M.","year":"2006","unstructured":"Na M, Yang S, He L, Oh H, Kim BS, Oh WK, Kim BY, Ahn JS.  Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata.","journal-title":"Planta Med"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.bmcl.2006.03.036","volume":"16","author":"Na M.","year":"2006","unstructured":"Na M, Cui L, Min BS, Bae K, Yoo JK, Kim BY, Oh WK, Ahn JS.  Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.bmcl.2006.03.036","volume":"16","author":"Na M.","year":"2006","unstructured":"Na M, Cui L, Min BS, Bae K, Yoo JK, Kim BY, Oh WK, Ahn JS.  Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/14756360600741560","volume":"21","author":"Kim S.","year":"2006","unstructured":"Kim S, Na M, Oh H, Jang J, Sohn CB, Kim BY, Oh WK, Ahn JS.  PTP1B inhibitory activity of kaurane diterpenes isolated from Siegesbeckia glabrescens.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1248\/bpb.30.379","volume":"30","author":"Na M.","year":"2007","unstructured":"Na M, Kim KA, Oh H, Kim BY, Oh WK, Ahn JS.  Protein tyrosine phosphatase 1B inhibitory activity of amentoflavone and its cellular effect on tyrosine phosphorylation of insulin receptors.","journal-title":"Biol Pharm Bull"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0031-1280377","volume":"78","author":"Steinmann D.","year":"2012","unstructured":"Steinmann D, Baumgartner RR, Heiss EH, Bartenstein S, Atanasov AG, Dirsch VM, Ganzera M, Stuppner H.  Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors.","journal-title":"Planta Med"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ptr.1935","volume":"20","author":"Yang S.","year":"2006","unstructured":"Yang S, Na MK, Jang JP, Kim KA, Kim BY, Sung NJ, Oh WK, Ahn JS.  Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans.","journal-title":"Phytother Res"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/np0601861","volume":"69","author":"Na M.","year":"2006","unstructured":"Na M, Jang J, Njamen D, Mbafor JT, Fomum ZT, Kim BY, Oh WK, Ahn JS.  Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii.","journal-title":"J Nat Prod"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1016\/j.bmcl.2007.05.005","volume":"17","author":"Na M.","year":"2007","unstructured":"Na M, Hoang DM, Njamen D, Mbafor JT, Fomum ZT, Thuong PT, Ahn JS, Oh WK.  Inhibitory effect of 2-arylbenzofurans from Erythrina addisoniae on protein tyrosine phosphatase-1B.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/np060477+","volume":"70","author":"Cui L.","year":"2007","unstructured":"Cui L, Ndinteh DT, Na M, Thuong PT, Silike-Muruumu J, Njamen D, Mbafor JT, Fomum ZT, Ahn JS, Oh WK.  Isoprenylated flavonoids from the stem bark of Erythrina abyssinica.","journal-title":"J Nat Prod"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1248\/cpb.56.85","volume":"56","author":"Jang J.","year":"2008","unstructured":"Jang J, Na M, Thuong PT, Njamen D, Mbafor JT, Fomum ZT, Woo E-R, Oh WK.  Prenylated flavonoids with PTP1B inhibitory activity from the root bark of Erythrina mildbraedii.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1016\/j.bmcl.2010.08.144","volume":"20","author":"Qin J.","year":"2010","unstructured":"Qin J, Su H, Zhang Y, Gao J, Zhu L, Wu X, Pan H, Li X.  Highly brominated metabolites from marine red alga Laurencia similis inhibit protein tyrosine phosphatase 1B.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1271\/bbb.110137","volume":"75","author":"Moon H.E.","year":"2011","unstructured":"Moon HE, Islam N, Ahn BR, Chowdhury SS, Sohn HS, Jung HA, Choi JS.  Protein tyrosine phosphatase 1B and \u03b1-glucosidase inhibitory Phlorotannins from edible brown algae, Ecklonia stolonifera and Eisenia bicyclis.","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/molecules19021663","volume":"19","author":"Chen Y-P.","year":"2014","unstructured":"Chen Y-P, Yang C-G, Wei P-Y, Li L, Luo D-Q, Zheng Z-H, Lu XH.  Penostatin derivatives, a novel kind of protein phosphatase 1b inhibitors isolated from solid cultures of the entomogenous fungus Isaria tenuipes.","journal-title":"Molecules"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.3390\/molecules200611173","volume":"20","author":"Quang T.H.","year":"2015","unstructured":"Quang TH, Ngan NT, Yoon CS.  Kim Protein Tyrosine Phosphatase 1B Inhibitors from the Roots of Cudrania tricuspidata.","journal-title":"Molecules"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1016\/j.bmcl.2005.08.099","volume":"15","author":"Lee B.W.","year":"2005","unstructured":"Lee BW, Lee JH, Lee ST, Lee HS, Lee WS, Jeong TS, Park KH.  Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/np030481a","volume":"68","author":"Lee B.W.","year":"2005","unstructured":"Lee BW, Gal SW, Park KM, Park KH.  Cytotoxic xanthones from Cudrania tricuspidata.","journal-title":"J Nat Prod"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/np070059k","volume":"70","author":"Hwang J.H.","year":"2007","unstructured":"Hwang JH, Hong SS, Han XH, Hwang JS, Lee D, Lee H, Yun YP, Kim Y, Ro JS, Hwang BY.  Prenylated xanthones from the root bark of Cudrania tricuspidata.","journal-title":"J Nat Prod"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0031-9422(95)00609-5","volume":"41","author":"Lee I.K.","year":"1996","unstructured":"Lee IK, Kim CJ, Song KS, Kim HM, Koshino H, Uramoto M, Yoo ID.  Cytotoxic benzyl dihydroflavonols from Cudrania tricuspidata.","journal-title":"Phytochemistry"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/np50124a024","volume":"58","author":"Lee I.K.","year":"1995","unstructured":"Lee IK, Kim CJ, Song KS, Kim HM, Yoo ID, Koshino H, Esumi Y, Uramoto M.  Two benzylated dihydroflavonols from Cudrania tricuspidata.","journal-title":"J Nat Prod"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hlca.201400096","volume":"97","author":"Lei C.","year":"2014","unstructured":"Lei C, Liu CC, Pi EH, Hou AJ.  New Isoprenylated Xanthones from Cudrania tricuspidata.","journal-title":"Helv Chim Acta"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10286020600782355","volume":"9","author":"Liang B.","year":"2007","unstructured":"Liang B, Li HR, Xu LZ, Yang SL.  Xanthones from the roots of Cudrania fruticosa Wight.","journal-title":"J Asian Nat Prod Res"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bmc.2004.01.030","volume":"12","author":"Zou Y.S.","year":"2004","unstructured":"Zou YS, Hou AJ, Zhu GF, Chen YF, Sun HD, Zhao QS.  Cytotoxic isoprenylated xanthones from Cudrania tricuspidata.","journal-title":"Bioorg Med Chem"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1016\/j.bmc.2009.02.042","volume":"17","author":"Ryu Y.B.","year":"2009","unstructured":"Ryu YB, Curtis-Long MJ, Lee JW, Kim JH, Kim JY, Kang KY, Lee WS, Park KH.  Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.","journal-title":"Bioorg Med Chem"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/np5002797","volume":"77","author":"Jo Y.H.","year":"2014","unstructured":"Jo YH, Shin B, Liu Q, Lee KY, Oh DC, Hwang BY, Lee MK.  Antiproliferative prenylated xanthones and benzophenones from the roots of Cudrania tricuspidata in HSC-T6 cells.","journal-title":"J Nat Prod"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1248\/cpb.25.529","volume":"25","author":"Nomura T.","year":"1997","unstructured":"Nomura T, Fukai T, Katayanagi M, Kuwanon AAB.  C and oxydihydromorusin, four new flavones from the root bark of the cultivated mulberry tree (Morus alba L.).","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bmcl.2015.12.021","volume":"26","author":"Wang Y.","year":"2016","unstructured":"Wang Y, Yuk HJ, Kim JY, Kim DW, Song YH, Tan XF, Curtis-Long MJ, Park KH.  Novel chromenedione derivatives displaying inhibition of protein tyrosine phosphatase 1B (PTP1B) from Flemingia philippinensis.","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:03:12Z","timestamp":1558764192000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169572\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,11]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666190201152153","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}